The specificity of chromium nucleotides as inhibitors of selected kinases.
D000085:Acetates; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D001665:Binding Sites; D002857:Chromium / Q000494:pharmacology*; D003402:Creatine Kinase / Q000037:antagonists & inhibitors; D003597:Cytosine Nucleotides / Q000494:pharmacology; D011756:Diphosphates / Q000494:pharmacology; D005990:Glycerol; D006150:Guanine Nucleotides / Q000494:pharmacology; D006593:Hexokinase / Q000037:antagonists & inhibitors; D007292:Inosine Nucleotides / Q000494:pharmacology; D008274:Magnesium / Q000378:metabolism; D009711:Nucleotides / Q000378:metabolism; D010428:Pentosephosphates / Q000494:pharmacology; D010710:Phosphates / Q000494:pharmacology; D010735:Phosphoglycerate Kinase / Q000037:antagonists & inhibitors; D010770:Phosphotransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011485:Protein Binding; D011770:Pyruvate Kinase / Q000037:antagonists & inhibitors; D012265:Ribonucleotides / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D014500:Uracil Nucleotides / Q000494:pharmacology
D000085:Acetates; D003597:Cytosine Nucleotides; D011756:Diphosphates; D006150:Guanine Nucleotides; D007292:Inosine Nucleotides; D009711:Nucleotides; D010428:Pentosephosphates; D010710:Phosphates; D012265:Ribonucleotides; D014500:Uracil Nucleotides; D002857:Chromium; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D010770:Phosphotransferases; D006593:Hexokinase; D011770:Pyruvate Kinase; D010735:Phosphoglycerate Kinase; D003402:Creatine Kinase; D008274:Magnesium; D005990:Glycerol